logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
24/12/2025
Libya's Prime Minister Debeba mourns the death of the Chief of Staff of the Libyan Army, whose plane lost signal in the airspace over Ankara, Turkey.
Latest
6 m ago
Change in USD bonds | Greenland Holdings Group GRNLGR 5.875 07/03/30 price increased by 3.288% to 9.848.
8 m ago
Spot platinum touched a record high of $2285.25 per ounce.
10 m ago
After the Bondi Beach shooting, the New South Wales Parliament in Australia passed an anti-terrorism emergency law.
27 m ago
Citius Oncology (CTOR.US): The revenue in the Q4 2025 financial report was 0 US dollars, the same as the previous value; the earnings per share were -0.06 US dollars, compared to -0.14 US dollars, and the expected value was -0.06 US dollars.
30 m ago
Citius Pharma (CTXR.US): The Q4 revenue report for 2025 showed a revenue of $0, same as the previous value, with an expected value of $5.756 million; earnings per share were -$0.11, compared to the previous value of -$1.72, and an expected value of -$0.24.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.